New study aims to catch transplant complications early with blood and urine tests

NCT ID NCT01644903

Recruiting now Knowledge-focused Sponsor: Northwestern University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is looking at 1,000 liver transplant recipients to see if testing their blood, urine, and tissue samples can detect early signs of chronic kidney disease, acute rejection, or hepatitis C. The goal is to find simple biomarkers that could lead to earlier treatment and fewer repeat transplants. Participants will provide samples over time, and researchers will track their health outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to a simple blood or urine test to catch complications early after a liver transplant, potentially reducing the need for repeat transplants.
What could go wrong: This is an observational study, not testing a new treatment. The biomarkers may not prove accurate enough for routine use, and results may take years to confirm.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE REJECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute transplant rejection chronic kidney disease chronic renal failure syndrome hepatitis C virus infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE REJECTION CHRONIC KIDNEY DISEASE HEPATITIS C LIVER TRANSPLANT

Contacts and locations

Locations

Northwestern Memorial Hospital
RECRUITING

Chicago, Illinois, 60611, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.